Updated Map Shows CDC’s Investments to Fight Antimicrobial ResistanceExplore efforts happening in your state or country |
---|
Today, CDC released the updated Antimicrobial Resistance (AR) Investment Map, highlighting CDC’s AR funding to global and domestic partners—from academic centers to local public health departments. These partners work alongside CDC to implement innovative solutions to slow the spread of AR, improve infection prevention and control (IPC), and protect people. CDC’s investments have strengthened U.S. and global capacities to rapidly detect, respond to, and contain known and emerging AR threats. |
---|
Each year, more than 3 million people in the U.S. get an antimicrobial-resistant infection or Clostridioides difficile infection (often associated with taking antibiotics). In fiscal year 2023, CDC invested more than $155 million of annual funding to support health departments and partners in the United States and abroad to combat and prevent antimicrobial-resistant infections. CDC also invested more than $265 million from temporary supplemental funding to fight a range of infections that threaten the nation’s health, including those caused by antimicrobial-resistant organisms, COVID-19, and other known and emerging infectious diseases. CDC leads the U.S. public health response to combat AR, a threat that continues to emerge and spread across the world. CDC’s AR Solutions Initiative invests in national infrastructure to detect, respond to, contain, and prevent resistant infections across healthcare settings, communities, the food supply, and the environment (water, soil). With sustained resources, CDC will continue to support its domestic and global AR programs to respond to whatever threat comes next. Highlights of this year’s AR Investment Map release include:
|
---|
#AntimicrobialResistance can spread quickly across countries and continents. #CDCfightsAR with millions in investments to support lab, epi, and innovation in the U.S. & more than 60 countries this year: https://bit.ly/3YoEuI0 |
---|